Skip to main content
Home

Top menu InfoLep

  • About InfoLep

Main navigation

  • Home
  • Leprosy [5]
    • Global and Regional Leprosy Situation
    • WHO Global Leprosy Strategy
    • ILEP Strategy
    • World Leprosy Day 2022
    • Leprosy journals
  • Key topics [7]
    • Leprosy and COVID-19
    • Diagnostic tests
    • Prevention of leprosy [2]
      • Interventions to reduce transmission: post-exposure prophylaxis (PEP) [3]
        • LPEP Programme
        • PEP++ project
        • PEP4LEP project
      • Interventions to reduce transmission: vaccines
    • Rehabilitation & prevention of disability [2]
      • Preventing leprosy-related disabilities in girls and boys
      • Self-care in leprosy
    • Antimicrobial resistance in leprosy
    • Stigma, discrimination & mental wellbeing [4]
      • World Leprosy Day 2022
      • Gender
      • Mental wellbeing
      • SARI Project
    • Bioarchaeology of leprosy
  • Toolkits [6]
    • Guides on Stigma and Mental Wellbeing [5]
      • Guide 1. What are health-related stigma and mental wellbeing? [8]
        • 1. What is stigma?
        • 2. Why does stigma exist?
        • 3. What are the causes of stigma?
        • 4. Who stigmatises?
        • 5. How does it feel to experience stigma?
        • 6. What are the effects of stigma?
        • 7. Effects of stigma and discrimination on mental wellbeing
        • Annex Guide 1
      • Guide 2. How to reduce the impact of stigma [7]
        • 1. From undetected disease to diagnosis to support
        • 2. Individual-level interventions
        • 3. Group-level interventions
        • 4. Family-level interventions
        • 5. Referral
        • 6. Further reading
        • Annexes Guide 2
      • Guide 3. How to reduce sources of stigma [6]
        • 1. Background to the design of a stigma-reduction intervention
        • 2. Identifying the sources of stigma
        • 3. Targeting an intervention
        • 4. Inclusion of affected persons and champions in interventions
        • 5. Interventions by source type
        • Annexes Guide 3
      • Guide 4. How to assess health-related stigma and mental wellbeing [9]
        • 1. What is the purpose of the assessment?
        • 2. What approach would best fit your purpose and context?
        • 3. Quantitative assessment methods
        • 4. Qualitative assessment methods
        • 5. Assessments using mixed methods
        • 6. Developing qualitative methods from scratch
        • 7. How do you conduct a stigma assessment?
        • 8. How to interpret and report your findings
        • Annexes Guide 4
      • Glossary
    • NTD Morbidity and Disability Toolkit [15]
      • CHIEF
      • Clinical Profile
      • EMIC affected persons
      • EMIC-CS Community Stigma
      • Participation Scale
      • Patient Health Questionnaire (PHQ-9)
      • 5-Question Stigma Indicators
      • Salsa Scale
      • SARI Stigma Scale
      • SDS Social Distance Scale
      • SRQ Self-reporting Questionnaire
      • Warwick-Edinburgh Mental Wellbeing Scale (WEMWBS)
      • WGQ Washington Group Questions
      • WHODAS
      • WHOQOL-BREF
    • Perception Study Toolkit (PST)
    • Zero Leprosy Toolkit
    • CBM's Community Mental Health Good Practice Guides
    • GPZL & Infolep Factsheets
  • Publications
  • Organizations

Top menu - mobile infoLep

  • About InfoLep

Search

Refine your results

Refine your results


Selected filters

  • Reset filters
  • Mycobacterium indicus pranii (MIP)

Filter by type

  • Publications only

NTD

  • Leprosy (Hansen disease) (24)
  • Leishmaniasis (3)

Subject

  • (-) Mycobacterium indicus pranii (MIP) (60)
  • Immunoprophylaxis / Vaccine (32)
  • Tuberculosis (17)
  • Contacts / Contact tracing (1)
  • Preventive Chemotherapy (PC) (3)
  • Children (1)
  • Erythema nodosum leprosum - enl (Type 2 reaction) (1)
  • SDR-PEP (1)
  • Transmission (1)
  • Complications and reactions (2)
  • Multi-drug therapy (MDT) (1)
  • Uniform multi-drug therapy (U-MDT) (1)
  • Prevention of disease (3)
  • Treatment (1)

Publication Type

  • Article (57)
  • Full text online (32)

Journal

  • American journal of reproductive immunology (New York, N.Y. : 1989) (1)
  • Analytical and bioanalytical chemistry (1)
  • Annals of clinical microbiology and antimicrobials (1)
  • Biologics : targets & therapy (1)
  • BMC infectious diseases (1)
  • Cancer biology & therapy (1)
  • Community skin health (1)
  • Dermatologic therapy (1)
  • FEMS immunology and medical microbiology (1)
  • Frontiers in microbiology (1)
  • Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie (1)
  • Immunology (1)
  • Indian journal of dermatology, venereology and leprology (1)
  • Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases (1)
  • Infectious disorders drug targets (1)
  • International immunology (1)
  • International immunopharmacology (1)
  • International journal of cancer (1)
  • International Journal of Contemporary Pediatrics (1)
  • International journal of medical microbiology : IJMM (2)
  • International journal of molecular sciences (1)
  • International Journal of Vaccine Research (1)
  • Journal of critical care (1)
  • Journal of leukocyte biology (2)
  • Journal of medical discovery (1)
  • Journal of reproductive immunology (1)
  • Journal of the European Academy of Dermatology and Venereology : JEADV (1)
  • Journal of translational science (1)
  • mBio (3)
  • Microbes and infection (1)
  • Molecular carcinogenesis (1)
  • Nucleic acids research (1)
  • Oncoimmunology (1)
  • PloS one (7)
  • Scientific reports (2)
  • Seminars in immunology (1)
  • The British journal of dermatology (1)
  • The FEBS journal (1)
  • The Indian journal of medical research (1)
  • The Indian journal of tuberculosis (1)
  • The Journal of antimicrobial chemotherapy (1)
  • The New England journal of medicine (1)
  • Tuberculosis (Edinburgh, Scotland) (2)
  • Vaccine (3)

Year of Publication

  • 2021 (1)
  • 2019 (4)
  • 2018 (2)
  • 2017 (6)
  • 2016 (10)
  • 2015 (10)
  • 2014 (7)
  • 2013 (3)
  • 2012 (9)
  • 2011 (4)
  • 2009 (1)
  • 2007 (1)

Language

  • English (56)

Regional focus

  • South-East Asia Region (SEAR) (8)
    • India (8)
 
  • Relevance
  • Date
60 items

Publication

Recurrent Erythema Nodosum Leprosum Associated With Mycobacterium Indicus Pranii Vaccine In A Case Of Leprosy: A Rare paradox.

Kothari R, Vashisht D, Pudasaini N, et al. Journal of the European Academy of Dermatology and Venereology : JEADV. 2021;

Publication

Raman spectroscopy reveals distinct differences between two closely related bacterial strains, Mycobacterium indicus pranii and Mycobacterium intracellulare.

Verma T, Podder S, Mehta M, et al. Analytical and bioanalytical chemistry. 2019;

Publication

Lipoarabinomannan from Mycobacterium indicus pranii shows immunostimulatory activity and induces autophagy in macrophages.

Singh B, Saqib M, Chakraborty A, et al. PloS one. 2019; 14 (10) : e0224239.
Download PDF

Publication

National leprosy symposium 2018

Community skin health. 2019;
Download PDF

Publication

Cell wall fraction of Mycobacterium indicus pranii shows potential Th1 adjuvant activity.

Saqib M, Khatri R, Singh B, et al. International immunopharmacology. 2019;

Publication

Potential of adjunctive Mycobacterium w (MIP) immunotherapy in reducing the duration of standard chemotherapy against tuberculosis.

Chahar M, Rawat KD, Reddy P V J, et al. The Indian journal of tuberculosis. 2018; 65 (4) : 335-344.

Publication

Mycobacterium indicus pranii protein MIP_05962 induces Th1 cell mediated immune response in mice.

Sharma A, Saqib M, Sheikh J, et al. International journal of medical microbiology : IJMM. 2018;

Publication

Gonadotropin and tumorigenesis: Direct and indirect effects on inflammatory and immunosuppressive mediators and invasion.

Khare P, Bose A, Singh P, et al. Molecular carcinogenesis. 2017; 56 (2) : 359-370.

Publication

Making of an immuno therapeutic cum immuno prophylactic vaccine against leprosy endowed with multiple properties and useful applications

Talwar G P, Zaheer S A, Gupta S, et al. Journal of medical discovery. 2017; 2 (4) : 1-8.
Download PDF

Publication

Launching Of Immunization with the Vaccine Mycobacterium Indicus Pranii for Eradication of Leprosy in India

Talwar G P, Jagdish G. International Journal of Vaccine Research. 2017;
Download PDF

Publication

Development of a potent invigorator of immune responses endowed with both preventive and therapeutic properties.

Talwar G, Gupta JC, Mustafa A, et al. Biologics : targets & therapy. 2017;
Download PDF

Publication

Efficacy and Safety of Mycobacterium indicus pranii as an adjunct therapy in Category II pulmonary tuberculosis in a randomized trial.

Sharma S, Katoch K, Sarin R, et al. Scientific reports. 2017; 7 (1) : 3354.
Download PDF

Publication

Immunodominant protein MIP_05962 from Mycobacterium indicus pranii displays chaperone activity.

Sharma A, Equbal M A, Pandey S, et al. The FEBS journal. 2017;

Publication

Addition of Mycobacterium indicus pranii (MIP) vaccine as an immunotherapeutic with standard chemotherapy in borderline leprosy: A double blind study to assess clinical improvement (A preliminary report).

Kamal R, Pathak V, Kumari A, et al. The British journal of dermatology. 2016;

Publication

Mycobacterium indicus pranii (Mw)-mediated protection against visceral leishmaniasis by reciprocal regulation of host dual-specificity phosphatases.

Parveen S, Bandhyopadhyay S, Das S, et al. International immunology. 2016; 28 (12) : 585-595.

Publication

Mycobacterium indicus pranii as a booster vaccine enhances BCG induced immunity and confers higher protection in animal models of tuberculosis.

Saqib M, Khatri R, Singh B, et al. Tuberculosis (Edinburgh, Scotland). 2016;

Publication

Preparation, Characterization and in Vivo Antimycobacterial Studies of Panchovillin-Chitosan Nanocomposites.

Rwegasila E, Mubofu EB, Nyandoro SS, et al. International journal of molecular sciences. 2016;
Download PDF

Publication

Cytotoxic and apoptotic effects of heat killed Mycobacterium indicus pranii (MIP) on various human cancer cell lines.

Subramaniam M, In L, Kumar A, et al. Scientific reports. 2016;
Download PDF

Publication

Addition of immunotherapy to chemotherapy in pediatric borderline leprosy: a clinical evaluation

Kamal R, M. N, R. D. International Journal of Contemporary Pediatrics. 2016;
Download PDF

Publication

Mycobacterium indicus pranii (MIP) mediated host protective intracellular mechanisms against tuberculosis infection: Involvement of TLR-4 mediated signaling.

Das S, Chowdhury BP, Goswami A, et al. Tuberculosis (Edinburgh, Scotland). 2016;

Pagination

  • Current page 1
  • Page 2
  • Page 3
  • Next page Next ›
  • Last page Last »

Use Ris for EndNote, Mendeley, RefWorks, Zotero and most other reference management software.

Quick links

  • Leprosy
  • Key topics
  • Toolbox
  • Publications
  • Organizations

Support

  • Contact
  • Privacy statement
  • Contact
  • FAQ

Contact us

info@infolep.org

(+31) 20 595 0500

     

Stay up to date with the latest publications and news related to leprosy.

Subscribe to newsletter

Related websites:

  • infontd

© 2022 InfoNTD